Danish pharmaceutical giant Novo Nordisk sees shares plummet nearly 20% after forecasting sales and earnings declines for 2026, while rival Eli Lilly reports surging profits from weight loss drug Mounjaro.
Pharmaceutical giant GSK posts 7% profit increase for 2025 driven by HIV and asthma treatments, but warns of moderating growth in 2026 under new CEO Luke Miels.
Novo Nordisk has revised down its revenue forecasts for blockbuster drugs Wegovy and Ozempic, leading to a sharp decline in its share price amid market concerns.
Sharon Vickers, 46, from South Carolina, turned to the new Wegovy oral medication after finding GLP-1 injections unaffordable at $500 monthly, achieving weight loss breakthrough.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Pharmaceutical giant GSK reveals increased profits driven by HIV and asthma treatments, but warns of moderating growth in 2026 under new CEO Luke Miels.
A Democratic congressman has issued fresh criticism regarding the FDA's accelerated drug review scheme, questioning its transparency, legal authority, and potential ethical conflicts among senior officials involved in the process.
MHRA data reveals alarming 340% increase in adverse reactions to weight loss drug Mounjaro, with 71 fatalities recorded in 2025. Gastrointestinal disorders dominate reports as patient stories highlight severe side effects.
NHS England identifies 378 medicines with single or no suppliers, threatening treatments for cancer, stroke and schizophrenia. A new scheme aims to incentivise manufacturers.
An eight-year-old girl from Indiana was hospitalised after injecting herself with her mother's GLP-1 medication, suffering severe symptoms and highlighting safety concerns.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Weight loss medications like Ozempic and Wegovy are causing seismic shifts across multiple sectors, reducing spending on groceries and fast food while impacting airlines, fashion, and alcohol consumption.
Pharmaceutical giant GSK is set to cut up to 350 research and development roles across its UK and US operations as part of a strategic overhaul of its R&D division.
Pharmaceutical giant GSK announces up to 350 research and development job cuts across the US and UK, including approximately 50 positions at its Stevenage hub, as part of ongoing restructuring.
Pharmaceutical giant GSK is eliminating up to 350 research and development positions across the UK and United States as part of ongoing divisional restructuring, with around 50 UK jobs already affected at its Stevenage hub.
UK pharmaceutical giant AstraZeneca has commenced trading on the New York Stock Exchange, delisting from Nasdaq as part of its global growth strategy targeting the US market.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Blood Cancer UK, Lymphoma Action and Anthony Nolan formally appeal against Nice's recommendation to remove Tecartus, a CAR T-cell therapy for mantle cell lymphoma, from NHS availability in England and Wales.
Patients taking the commonly prescribed medication gabapentin for nerve pain or epilepsy are being urged to contact a doctor immediately if they develop any of five specific serious symptoms.
Weight loss medications like Ozempic and Wegovy are causing seismic shifts across multiple sectors, reducing food and alcohol spending while impacting airlines, fashion, and fitness markets.
Medical regulators urge vigilance for rare but severe pancreatitis symptoms in patients using popular GLP-1 medications like Ozempic, Wegovy and Mounjaro across the UK.
Pharmaceutical giant Eli Lilly announces a major $3.5 billion manufacturing facility in Pennsylvania, expanding domestic production to meet soaring demand for its obesity and diabetes treatments.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
The NHS advises nine specific groups to consult doctors before taking amitriptyline for pain relief, depression, or migraines. Key warnings include heart conditions, pregnancy, and medication interactions.
The only licensed immunotherapy for peanut allergy in young people is being discontinued globally, described as a commercial decision that leaves families without treatment options.
The MHRA has updated safety information for Wegovy, Ozempic and Mounjaro to highlight a small but serious risk of severe acute pancreatitis, following a UK death linked to the medication.
AstraZeneca announces a major £13.4 billion partnership with China's CSPC to develop monthly weight loss injections, aiming to challenge market leaders like Ozempic.
Former President Donald Trump reveals pharmaceutical giant Eli Lilly plans to construct six new manufacturing facilities across the United States, expanding on previous investment announcements.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Britain's largest pharmaceutical firm AstraZeneca reveals a major $15bn investment in China during Keir Starmer's visit, months after scaling back UK expansion plans amid government disputes.
The MHRA has confiscated over 27,000 units of unlicensed dermal fillers since 2020, valued at up to £4 million, with a sharp rise in seizures in 2023.
The Medicines and Healthcare products Regulatory Agency has confiscated over 27,000 unlicensed dermal filler units since 2020, warning they pose serious health risks including disfigurement and infection.
British pharmaceutical giant AstraZeneca has announced a major $15 billion investment in China by 2030, the largest deal of Prime Minister Keir Starmer's diplomatic visit to Beijing.
Thousands of patients have filed lawsuits against pharmaceutical companies, alleging severe side effects from popular weight-loss injections like Ozempic and Wegovy.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Thousands of patients are suing pharmaceutical giants over severe side effects from GLP-1 weight-loss drugs, including eye strokes and ruptured colons, despite company assurances of rigorous testing.
